Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media
More topics under "C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media" (918,689)
C12N 1 - Micro-organisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving micro-organisms or compositions thereof; Processes of preparing or isolating a composition containing a micro-organism; Culture media therefor (148,866)
C12N 11 - Carrier-bound or immobilised enzymes; Carrier-bound or immobilised microbial cells; Preparation thereof (12,439)
C12N 13 - Treatment of micro-organisms or enzymes with electrical or wave energy, e.g. magnetism, sonic waves (3,958)
C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
C12N 3 - Spore-forming or isolating processes (415)
C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629)
C12N 7 - Viruses, e.g. bacteriophages; Compositions thereof; Preparation or purification thereof (26,637)
C12N 9 - Enzymes, e.g. ligases (6.); Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating, or purifying enzymes (141,535)
Patents for C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media (9,992)
06/2005
06/30/2005US20050142581 Methods for selecting a target molecule that has an affinity for a ligand that is equal to or greater than a baseline affinity wherein either one or both of the target molecule and ligand, independently, is a microRNA; mass spectrometry methods for detecting binding interactions of ligands to substrates
06/30/2005US20050142568 Kit for screening for an apoptosis modulator; an isolated cell death-related nuclease (CRN)polypeptide or fragment, polynucleotide encoding fragment, and/or orthologs; medical diagnosis; genetic engineering and expression; hybridization
06/30/2005US20050142561 Intracellular signaling pathways in diabetic subjects
06/30/2005US20050142559 Amplification of DNA in a hairpin structure, and applications
06/30/2005US20050142557 Polynucleotides and polypeptides of Anaplasma phagocytophilum and methods of using the same
06/30/2005US20050142534 Treat cells growth regions with endonuclease, nucleic acid stain; evaluate interactions between cells, and between cells and matrix materials, cellular distribution patterns indicate invasive potential of cells; indicate preferred sites of metastasis, efficacy of an anticancer drug
06/30/2005US20050142179 Transfection reagents
06/30/2005US20050142143 Capable of accumulating in the endoplasmic reticulum; melanoma antigen; vaccines; treating melanoma
06/30/2005US20050142142 recombinant T cell receptor ligand (RTL) for use treating autoimmune diseases
06/30/2005US20050140460 Power conditioners and pseudo isolation for a two-wire processing network
06/30/2005CA2771330A1 Methods and materials for canine breed identification
06/30/2005CA2733144A1 Methods and materials for canine breed identification
06/30/2005CA2550893A1 Molecular signature of the pten tumor suppressor
06/30/2005CA2550219A1 Methods and materials for canine breed identification
06/30/2005CA2550192A1 Nucleic acid probes and broad-range primers from regions in dna directed rna polymerase subunit b genes, and methods in which they are used
06/30/2005CA2549324A1 Gene expression profiles and methods of use
06/30/2005CA2549303A1 Novel sodium channel
06/30/2005CA2548393A1 Chemokine receptor binding compounds
06/30/2005CA2548349A1 P ef-tu expression units
06/30/2005CA2547563A1 Corn plant mon88017 and compositions and methods for detection thereof
06/30/2005CA2546054A1 Interferon alpha antibodies and their uses
06/29/2005EP1546705A2 Transgenic animal and uses thereof
06/29/2005EP1546399A2 Terminal phosphate blocked nucleoside polyphosphates
06/29/2005EP1546396A2 Manufacturing method and readout system for biopolymer arrays
06/29/2005EP1546388A2 Real time measurement of cellular responses
06/29/2005EP1546387A2 Microarray synthesis and assembly of gene-length polynucleotides
06/29/2005EP1546385A2 Quantification of gene expression
06/29/2005EP1546383A2 Isolation of genetic molecules from a complex biological construct for use in genetic expression analysis
06/29/2005EP1546301A2 Device and methods for isolating target cells
06/29/2005EP0773957B1 Secreted hepatitis C virus E1/E2 complex obtained from C-terminally truncated E1 and E2 polypeptides
06/29/2005CN1633448A Method for the generation of genetically modified vertebrate precursor lymphocytes and use thereof for the production of heterologous binding proteins
06/29/2005CN1208450C Method for the purification, recovery, and sporulation of cysts and oocysts
06/23/2005WO2005056771A2 In vitro uptake of spam 1 (ph-20) by mammalian sperm
06/23/2005WO2005056770A2 Band 5: a human testis specific protein
06/23/2005WO2005056769A2 Orally-administered live bacterial vaccines for plague
06/23/2005WO2005056768A2 Methods of designing, synthesizing, and propagating reference nucleic acids
06/23/2005WO2005056766A2 TARGETED DRUG DELIVERY USING EphA2 OR Eph4 BINDING MOIETIES
06/23/2005WO2005056765A2 Methods for culturing keratinocytes from human embryonic stem cells
06/23/2005WO2005056764A2 Inhibitors of type 2 vascular endothelial growth factor receptors
06/23/2005WO2005056763A2 Process and formulation to improve viability of stored cells and tissue
06/23/2005WO2005056762A2 Truncated cmv promoters and vectors containing same
06/23/2005WO2005056761A2 REAGENTS AND METHODS FOR IDENTIFICATION OF RNAi PATHWAY GENES AND CHEMICAL MODULATORS OF RNAi
06/23/2005WO2005056760A2 Glycopegylated follicle stimulating hormone
06/23/2005WO2005056759A2 Methods of generating variant proteins with increased host string content and compositions thereof
06/23/2005WO2005056758A2 Methods and compositions for genetically detecting improved milk production traits in cattle
06/23/2005WO2005056756A2 Kinase suppressor of ras inactivation for therapy of ras mediated tumorigenesis
06/23/2005WO2005056755A2 Compositions and methods for propagation of neural progenitor cells
06/23/2005WO2005056754A2 Compositions and methods to reduce mutagenesis
06/23/2005WO2005056753A2 Methods of determining juvenile arthritis classification
06/23/2005WO2005056752A2 Methods and compositions for delivering polynucleotides
06/23/2005WO2005056751A2 Apparatus and method for concentrating stem cell
06/23/2005WO2005056750A2 Inversion-duplication of nucleic acids and libraries prepared thereby
06/23/2005WO2005049787A9 Compositions and methods for in vitro sorting of molecular and cellular libraries
06/23/2005WO2005042696A3 Apparatus receiving and aligning multiple electrode pair array and multiple treatment cell for electroporation
06/23/2005WO2005037999A9 Treatment of cancer using antibodies to lrrc15
06/23/2005WO2005037996A3 In vitro development of tissues and organs
06/23/2005WO2005014796A3 Methods and compositions for seamless cloning of nucleic acid molecules
06/23/2005WO2005012501A3 Free-solution dna sequencing
06/23/2005WO2005007814A3 Genome mapping of functional dna elements and cellular proteins
06/23/2005WO2005007808A3 Hiv polynucleotides and polypeptides derived from botswana mj4
06/23/2005WO2005005608A3 Compositions and methods for differentiating adipose stromal cells into pancratic beta cells
06/23/2005WO2004078928A3 T cell regulation
06/23/2005US20050137385 IL-23p40 specific immunoglobulin derived proteins, compositions, methods and uses
06/23/2005US20050136519 Production of polyunsaturated fatty acids in oleaginous yeasts
06/23/2005US20050136451 Hypoxia responsive human CNGH 0002 genes and polypeptides
06/23/2005US20050136449 For polypeptides having polyhistidine/polycysteine tags; cell extracts comprising nuclease inhibitors; kits
06/23/2005US20050136070 Isolation and characterization of the csa operon (ETEC-CS4 Pili) and methods of using same
06/23/2005US20050136054 Humanised antibodies
06/23/2005US20050136035 Targeted adenovirus vectors include co-transcribed genes under transcriptional control of the same heterologous transcriptional regulatory element (TRE), wherein a second gene is under translational control of a self processing cleavage sequence or 2A sequence; cell or tissue-targeted therapy; e.g. tumor
06/23/2005CA2552435A1 Inhibitors of type 2 vascular endothelial growth factor receptors
06/23/2005CA2549397A1 Methods and compositions for genetically detecting improved milk production traits in cattle
06/23/2005CA2549384A1 Kinase suppressor of ras inactivation for therapy of ras mediated tumorigenesis
06/23/2005CA2548817A1 Methods of generating variant proteins with increased host string content and compositions thereof
06/23/2005CA2548451A1 Methods of designing, synthesizing, and propagating reference nucleic acids
06/23/2005CA2547827A1 Compositions and methods for propagation of neural progenitor cells
06/23/2005CA2547425A1 Orally-administered live bacterial vaccines for plague
06/23/2005CA2543257A1 Methods and compositions for delivering polynucleotides
06/22/2005EP1543154A2 Abasic site endonuclease assay
06/22/2005EP1543024A2 Cyclic amp phosphodiesterase 4d7 isoforms and methods of use
06/22/2005CN1630721A Factor VII polypeptides for preventing formation of inhibitors in subjects with haemophilia
06/22/2005CN1630709A Human glucagon-like-peptide-1 mimics and their use in the treatment of diabetes and related conditions
06/16/2005WO2005054441A2 Device for immobilizing chemical and biomedical species and methods of using same
06/16/2005WO2005054440A2 A biomimetic composition reinforced by a polyelectrolytic complex of hyaluronic acid and chitosan
06/16/2005WO2005054439A2 Small interfering rna (sirna)-mediated heritable gene manipulation in plants
06/16/2005WO2005054438A2 Nucleic acid molecules containing recombination sites and methods of using the same
06/16/2005WO2005054437A2 Compositions and methods for ex vivo preservation of blood vessels for vascular grafts using inhibitor of type i and/or type ii phosphodiesterases
06/16/2005WO2005054436A2 Compositions and methods for preservation of vascular grafts
06/16/2005WO2005054435A2 Methods and compositions for in vitro amplification of extrachromosomal nucleic acid
06/16/2005WO2005054434A2 Use of notch pathway interfering agents for treatment of plasma cell disorders
06/16/2005WO2005054433A2 A novel “cleave-n-read” system for protease activity assay and methods of use thereof
06/16/2005WO2005054432A2 Gene transfer for regulating smooth muscle tone
06/16/2005WO2005054430A2 Hepatitis c virus inhibitors
06/16/2005WO2005054429A2 Synthesis of the c1-c6 keto-acid synthon of the epothilones
06/16/2005WO2005054428A2 Method for inhibiting cancer cells
06/16/2005WO2005054427A2 Target sequences for synthetic molecules
06/16/2005WO2005054426A2 Angiogenesis affecting polypeptides, proteins, and compositions, and methods of use thereof
06/16/2005WO2005040333A3 Ligand-pseudoreceptor system for generation of adenoviral vectors with altered tropism
06/16/2005WO2005028635A3 Microfluidic differential extraction cartridge
06/16/2005WO2005028632A3 Hyaluronan (ha) esterification via acylation technique for moldable devices
06/16/2005WO2005005598A3 B. anthracis luxs and furanone inhibition of a1-2 quorum sensing
1 ... 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 ... 100